Literature DB >> 28131663

Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.

Sergio Caravita1, Andrea Faini2, Gael Deboeck3, Antoine Bondue3, Robert Naeije3, Gianfranco Parati4, Jean-Luc Vachiéry5.   

Abstract

BACKGROUND: Excessive exercise-induced hyperventilation and high prevalence of exercise oscillatory breathing (EOB) are present in patients with post-capillary pulmonary hypertension (PH) complicating left heart disease (LHD). Patients with pre-capillary PH have even higher hyperventilation but no EOB. We sought to determine the impact of a pre-capillary component of PH on ventilatory response to exercise in patients with PH and left heart disease.
METHODS: We retrospectively compared patients with idiopathic or heritable pulmonary arterial hypertension (PAH, n = 29), isolated post-capillary PH (IpcPH, n = 29), and combined post- and pre-capillary PH (CpcPH, n = 12). Diastolic pressure gradient (DPG = diastolic pulmonary artery pressure - pulmonary wedge pressure) was used to distinguish IpcPH (DPG <7 mm Hg) from CpcPH (DPG ≥7 mm Hg).
RESULTS: Pulmonary vascular resistance (PVR) was higher in PAH, intermediate in CpcPH, and low in IpcPH. All patients with CpcPH but 1 had PVR >3 Wood unit. Exercise-induced hyperventilation (high minute ventilation over carbon dioxide production, low end-tidal carbon dioxide) was marked in PAH, intermediate in CpcPH, and low in IpcPH (p < 0.001) and correlated with DPG and PVR. Prevalence of EOB decreased from IpcPH to CpcPH to PAH (p < 0.001).
CONCLUSIONS: Patients with CpcPH may have worse hemodynamics than patients with IpcPH and distinct alterations of ventilatory control, consistent with more exercise-induced hyperventilation and less EOB. This might be explained at least in part by the presence and extent of pulmonary vascular disease.
Copyright © 2017 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiopulmonary exercise test; diastolic pressure gradient; oscillatory breathing; pulmonary hypertension; ventilation

Mesh:

Year:  2016        PMID: 28131663     DOI: 10.1016/j.healun.2016.12.011

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  16 in total

1.  Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: from the compliance to adaptation, maladaptation and reflexes.

Authors:  Carolina Lombardi; Sergio Caravita; Gianfranco Parati
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction.

Authors:  Chakradhari Inampudi; Daniel Silverman; Marc A Simon; Peter J Leary; Kavita Sharma; Brian A Houston; Jean-Luc Vachiéry; Francois Haddad; Ryan J Tedford
Journal:  Chest       Date:  2021-08-12       Impact factor: 9.410

3.  The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.

Authors:  Marco Vicenzi; Sergio Caravita; Irene Rota; Rosa Casella; Gael Deboeck; Lorenzo Beretta; Andrea Lombi; Jean-Luc Vachiery
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

Review 4.  Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?

Authors:  Srinath Adusumalli; Jeremy A Mazurek
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 5.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

Review 6.  Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.

Authors:  Andrea R Levine; Marc A Simon; Mark T Gladwin
Journal:  Trends Cardiovasc Med       Date:  2018-08-17       Impact factor: 6.677

Review 7.  Exercise Intolerance in Heart Failure: Central Role for the Pulmonary System.

Authors:  Sophie Lalande; Troy J Cross; Manda L Keller-Ross; Norman R Morris; Bruce D Johnson; Bryan J Taylor
Journal:  Exerc Sport Sci Rev       Date:  2020-01       Impact factor: 6.642

8.  Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease.

Authors:  Farhan Raza; Naga Dharmavaram; Timothy Hess; Ravi Dhingra; James Runo; Amy Chybowski; Callyn Kozitza; Supria Batra; Evelyn M Horn; Naomi Chesler; Marlowe Eldridge
Journal:  Clin Cardiol       Date:  2022-04-14       Impact factor: 3.287

9.  Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.

Authors:  Alessandro Santaniello; Rosa Casella; Marco Vicenzi; Irene Rota; Gaia Montanelli; Maria De Santis; Chiara Bellocchi; Federico Lombardi; Lorenzo Beretta
Journal:  Rheumatology (Oxford)       Date:  2020-07-01       Impact factor: 7.580

10.  The tailor-made treatment in a particular case of pulmonary hypertension in thalassaemia intermedia: a case report.

Authors:  Federico B M Blasi; Irene Rota; Giovanna Graziadei; Marco Vicenzi
Journal:  Eur Heart J Case Rep       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.